Inhibition of c-jun N terminal kinase (JNK) improves functional beta cell mass in human islets and leads to AKT and glycogen synthase kinase-3 (GSK-3) phosphorylation.

Source:http://linkedlifedata.com/resource/pubmed/id/18066521

Download in:

View as

General Info

PMID
18066521